| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Tom Luedde | |
| Fabian Benz | |||
| Christoph Roderburg | |||
| Sanchari Roy | |||
| P2860 | cites work | Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis | Q21560965 |
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| Advances in the techniques for the prediction of microRNA targets | Q24630030 | ||
| microRNA-122 stimulates translation of hepatitis C virus RNA | Q24654912 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| MicroRNAs as biomarkers for myocardial infarction | Q27000432 | ||
| The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis | Q27014062 | ||
| An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis | Q28235822 | ||
| Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells | Q28259784 | ||
| Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice | Q28507402 | ||
| Liver fibrosis | Q29547449 | ||
| Treatment of HCV infection by targeting microRNA | Q29547712 | ||
| Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis | Q31126487 | ||
| Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation | Q33588984 | ||
| MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis | Q33643242 | ||
| The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families | Q33808955 | ||
| MicroRNAs in liver disease | Q33880442 | ||
| A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules | Q33936112 | ||
| Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease | Q34009053 | ||
| Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction | Q34023700 | ||
| Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury | Q34283405 | ||
| Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway | Q34505974 | ||
| miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1 | Q34607960 | ||
| Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. | Q34611681 | ||
| Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell | Q35011209 | ||
| NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies | Q35022054 | ||
| Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. | Q35127629 | ||
| MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease | Q35157020 | ||
| Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury | Q35922580 | ||
| miR-122 regulates hepatic lipid metabolism and tumor suppression | Q36129151 | ||
| Epigenetic regulation of miR-34a expression in alcoholic liver injury. | Q36204201 | ||
| MicroRNA function: multiple mechanisms for a tiny RNA? | Q36325449 | ||
| Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection | Q36335088 | ||
| Discovering the first microRNA-targeted drug | Q36353486 | ||
| miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression | Q36747098 | ||
| microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. | Q36890242 | ||
| Hepatic function is preserved in the absence of mature microRNAs | Q37082768 | ||
| U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis | Q37212187 | ||
| Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 | ||
| Biological principles of microRNA-mediated regulation: shared themes amid diversity | Q37293110 | ||
| A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. | Q37631219 | ||
| Current strategies for microRNA research | Q37975146 | ||
| IL-13 Signaling in Liver Fibrogenesis | Q38010706 | ||
| Hepatic stellate cells--the pericytes in the liver | Q38071948 | ||
| Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs | Q38129926 | ||
| Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Q38190875 | ||
| The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats | Q38336979 | ||
| Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation | Q38502279 | ||
| Detection and quantification of extracellular microRNAs in murine biofluids. | Q38895005 | ||
| Overexpression of miR-126 inhibits the activation and migration of HSCs through targeting CRK. | Q39028893 | ||
| Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation | Q39062251 | ||
| Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells | Q39085136 | ||
| Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. | Q39095795 | ||
| MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling | Q39156529 | ||
| Activation of hepatic stellate cells is suppressed by microRNA-150. | Q39162909 | ||
| Induction of microRNA-214-5p in human and rodent liver fibrosis | Q39304895 | ||
| MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. | Q39324702 | ||
| Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling | Q39345427 | ||
| miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients | Q39374420 | ||
| Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis | Q39498041 | ||
| Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo | Q39499494 | ||
| Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation | Q39500247 | ||
| TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?. | Q39529070 | ||
| Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. | Q39681139 | ||
| Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis | Q39953406 | ||
| Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice. | Q41886234 | ||
| Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis | Q42144833 | ||
| Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients | Q42199832 | ||
| Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation | Q42450672 | ||
| Retinoid X receptor α in human liver is regulated by miR-34a. | Q42660683 | ||
| MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway | Q44765599 | ||
| miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis | Q45749834 | ||
| Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases | Q46045622 | ||
| Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation | Q46137385 | ||
| Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients | Q50734531 | ||
| Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease | Q50786458 | ||
| Developmental biology. Encountering microRNAs in cell fate signaling. | Q52033155 | ||
| Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. | Q53035307 | ||
| microRNA-222 modulates liver fibrosis in a murine model of biliary atresia. | Q53064912 | ||
| MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. | Q54327847 | ||
| Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. | Q54394432 | ||
| Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide | Q73043085 | ||
| Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
| MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis | Q87422489 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 24-33 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Hepatobiliary surgery and nutrition | Q26842328 |
| P1476 | title | The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis | |
| P478 | volume | 4 |
| Q57169221 | A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases |
| Q61811185 | A Systematic Review of miR-29 in Cancer |
| Q47251438 | Adeno-Associated Virus 2 (AAV2)-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis |
| Q38650644 | Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis |
| Q49651931 | Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis |
| Q41043653 | Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke |
| Q28079138 | Involvement of inflammation and its related microRNAs in hepatocellular carcinoma |
| Q58712977 | Liver function tests in identifying patients with liver disease |
| Q36301298 | Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA. |
| Q59356052 | MicroRNA-194 protects against chronic hepatitis B-related liver damage by promoting hepatocyte growth via ACVR2B |
| Q92684312 | MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma |
| Q38716244 | MicroRNAs associated with inflammation in shoulder tendinopathy and glenohumeral arthritis. |
| Q26768588 | Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis |
| Q64075673 | Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease |
| Q41283812 | Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma |
| Q35870539 | Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines |
| Q36969738 | The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study |
| Q39881002 | The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients |
| Q33868794 | The roles of microRNA families in hepatic fibrosis |
| Q90733109 | Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease |
| Q33786041 | Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients |
Search more.